Laci-2 trial results published The results of the Lacunar intervention 2 Trial (Laci-2) have been published in Lancet Neurology This randomised clinical trial tested the feasibility and effects of one year of isosorbide mononitrate (ISMN) and cilostazol treatment in 363 participants with lacunar stroke. The results indicate that these widely available drugs may reduce adverse vascular and cognitive outcomes. Further studies are now in preparation to validate these findings. Read the results in more detail here Read more about the study on the BHF trials website here This article was published on 2024-06-04